Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Plasmalyte A vs Ringer's lactate as cardiopulmonary bypass prime in diabetic patients undergoing cardiac surgery
IRCT20211031052921N1Phase 3Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Gluconic acid in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Rajaie Cardiovascular Medical and Research Center. Primary endpoints: Acid-base status, Electrolytes (sodium, potassium, calcium) and 2 more. Started Dec 2022; status: completed.
02
Drugs
Gluconic acid
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20211031052921N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211031052921N1.